Department of Orthopedics Trauma and Microsurgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China (mainland).
Med Sci Monit. 2020 Feb 12;26:e919925. doi: 10.12659/MSM.919925.
BACKGROUND Infected bone defects are therapeutic challenges. Although the induced membrane technique has been used for this problem, there is a 3% to 20.7% failure to eradicate infection, and there have been few reports about its use in tuberculous infection. We present our three-stage induced membrane technique (TSIMT) for treating infected bone defects of the lower extremity. MATERIAL AND METHODS Forty-one adult patients with infected bone defects of the lower extremities treated by TSIMT were included in a retrospective case-series study between January 2013 and June 2018. The clinical, imaging and laboratory assessment outcomes were analyzed. RESULTS In the first stage, 3 patients had ankle tuberculous bone defects and 17 patients underwent 2-4 debridements. In the second stage, the average bone defect was 6.0 cm; 1 patient needed an anterolateral thigh flap to cover the wound. In the third stage, 10 patients underwent autograft mixed allograft, and 18 cases used internal fixation. The mean follow-up period was 23.3 months. All patients achieved bone union and clinical eradication of infection. Changes in Lower Extremity Functional Scale (LEFS) scores after 1 year of TSIMT and bone union time are associated with advanced age, longer duration of infected bone defects, active smoking, and external fixation (p<0.05), but are not dependent on bone defect size, debridement times, type of bone graft, or spacer-placing time (p>0.05). CONCLUSIONS TSIMT is effective in treating infected bone defects of the lower extremities. Advanced age, longer duration of infected bone defects, active smoking, and external fixation adversely affect bone union and recovery of infected extremities in a limited time span.
感染性骨缺损是治疗的挑战。虽然诱导膜技术已被用于治疗此类问题,但仍有 3%至 20.7%的病例无法彻底清除感染,且鲜有关于其在结核感染中应用的报道。我们提出了一种用于治疗下肢感染性骨缺损的三阶段诱导膜技术(TSIMT)。
回顾性病例系列研究纳入了 2013 年 1 月至 2018 年 6 月期间采用 TSIMT 治疗的 41 例下肢感染性骨缺损的成年患者。分析了临床、影像学和实验室评估结果。
在第一阶段,3 例患者为踝关节结核性骨缺损,17 例患者接受了 2-4 次清创术。在第二阶段,平均骨缺损为 6.0cm;1 例患者需要使用股前外侧皮瓣覆盖创面。在第三阶段,10 例患者接受了自体骨混合同种异体骨移植,18 例患者采用内固定。平均随访时间为 23.3 个月。所有患者均实现了骨愈合和临床感染清除。TSIMT 治疗 1 年后的下肢功能量表(LEFS)评分变化和骨愈合时间与高龄、感染性骨缺损持续时间较长、吸烟和外固定有关(p<0.05),但与骨缺损大小、清创次数、植骨类型或间隔器放置时间无关(p>0.05)。
TSIMT 治疗下肢感染性骨缺损有效。高龄、感染性骨缺损持续时间较长、吸烟和外固定会对骨愈合和在有限时间内感染肢体的恢复产生不利影响。